Another consideration is cardiovascular outcomes which have been flagged from a recent meta-analysis [24] comparing the effect of ACE inhibitors or ARBs against other antihypertensives such as calcium channel blockers amongst Black people with hypertension with 4-to-6-year follow-up. Here, ACE is linked to Hypertension.